{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:30:23Z","timestamp":1783420223190,"version":"3.54.6"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bezmialem Research Fund of the Bezmialem Vak\u0131f University","award":["6.2016\/11"],"award-info":[{"award-number":["6.2016\/11"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bioorg.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T12:39:25Z","timestamp":1551962365000},"page":"838-850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma"],"prefix":"10.1016","volume":"87","author":[{"given":"Belma Zengin","family":"Kurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"Dag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Durdagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.bioorg.2019.03.003_b0005","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1016\/j.bmc.2015.10.018","article-title":"New natural product carbonic anhydrase inhibitors incorporating phenol moieties","volume":"23","author":"Karioti","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.03.003_b0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.bioorg.2019.03.003_b0015","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.bmc.2017.01.031","article-title":"Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: discovery of subnanomolar isoform II activators","volume":"25","author":"Le Duc","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2019.03.003_b0020","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.bioorg.2019.03.003_b0025","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.bmc.2017.07.056","article-title":"Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties","volume":"25","author":"Angeli","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2019.03.003_b0035","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2019.03.003_b0040","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.003_b0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2018.01.033","article-title":"Structural investigations on coumarins leading to chromeno[4,3-c] pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"146","author":"Bonardi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.bioorg.2019.03.003_b0050","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1016\/j.bmc.2015.09.041","article-title":"Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII","volume":"23","author":"Nocentini","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.003_b0055","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2017.11.061","article-title":"Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases","volume":"143","author":"De Luca","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.03.003_b0060","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmc.2016.11.039","article-title":"Coumarins and other fused bicyclic heterocycles with selective tumor-associated carbonic anhydrase isoforms inhibitory activity","volume":"25","author":"Bozdag","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2019.03.003_b0065","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cmdc.201700446","article-title":"Sulfocoumarin-, coumarin-, 4-sulfamoylphenyl-bearing indazole-3-carboxamide hybrids: synthesis and selective inhibition of tumor-associated carbonic anhydrase isozymes IX and XII","volume":"12","author":"Angapelly","year":"2017","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocounnarins (1,2-Benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2019.03.003_b0075","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bmc.2015.02.023","article-title":"Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action","volume":"23","author":"Grandane","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2019.03.003_b0080","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","article-title":"Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII","volume":"24","author":"Chandak","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.canlet.2016.01.031","article-title":"AK-1, a SIRT2 inhibitor, destabilizes HIF-1 alpha and diminishes its transcriptional activity during hypoxia","volume":"373","author":"Lee","year":"2016","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2019.03.003_b0090","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.tips.2006.09.002","article-title":"Targeting tumor-associated carbonic anhydrase IX in cancer therapy","volume":"27","author":"Thiry","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2019.03.003_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2019.03.003_b0100","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ejphar.2016.09.027","article-title":"SYP-5, a novel HIF-1 inhibitor, suppresses tumor cells invasion and angiogenesis","volume":"791","author":"Wang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.03.003_b0105","doi-asserted-by":"crossref","unstructured":"C.T. Supuran, V. Alterio, A. Di Fiore, K, D. A., F. Carta, S.M. Monti, G. De Simone, Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one. Med. Res. Rev., 2018.","DOI":"10.1002\/med.21497"},{"issue":"4","key":"10.1016\/j.bioorg.2019.03.003_b0110","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ajpath.2014.01.002","article-title":"Expression pattern of carbonic anhydrase IX in Medullary thyroid carcinoma supports a role for RET-mediated activation of the HIF pathway","volume":"184","author":"Takacova","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bioorg.2019.03.003_b0115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbrc.2017.08.107","article-title":"Exosomes expressing carbonic anhydrase 9 promote angiogenesis","volume":"492","author":"Horie","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6733","key":"10.1016\/j.bioorg.2019.03.003_b0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2019.03.003_b0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymeth.2017.07.002","article-title":"Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: a systematic review","volume":"130","author":"Peerlings","year":"2017","journal-title":"Methods"},{"issue":"17","key":"10.1016\/j.bioorg.2019.03.003_b0130","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1016\/j.bmc.2015.07.066","article-title":"Exploring new Probenecid-based carbonic anhydrase inhibitors: synthesis, biological evaluation and docking studies","volume":"23","author":"Mollica","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14756366.2016.1235040","article-title":"Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms","volume":"32","author":"D\u2019Ascenzio","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.003_b0140","doi-asserted-by":"crossref","unstructured":"A. Mollica, G. Macedonio, A. Stefanucci, S. Carradori, A. Akdemir, A. Angeli, C.T. Supuran, Five- and six-membered nitrogen-containing compounds as selective carbonic anhydrase activators. Molecules, 2017, vol. 22, 12 pii: E2178. 10.3390\/molecules22122178.","DOI":"10.3390\/molecules22122178"},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/14756366.2018.1468530","article-title":"Activation of \u03b2- and \u03b3-carbonic anhydrases from pathogenic bacteria with tripeptides","volume":"33","author":"Stefanucci","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2019.03.003_b0150","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2019.03.003_b0160","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","article-title":"7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"14","key":"10.1016\/j.bioorg.2019.03.003_b0165","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1016\/j.bmc.2010.06.028","article-title":"Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations","volume":"18","author":"Wagner","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0170","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/14756366.2017.1354857","article-title":"Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors","volume":"32","author":"Kurt","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2019.03.003_b0175","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1016\/j.bmc.2013.05.032","article-title":"7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors","volume":"21","author":"Tanc","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2019.03.003_b0180","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","article-title":"Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"13","key":"10.1016\/j.bioorg.2019.03.003_b0185","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/acs.jmedchem.6b00609","article-title":"Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti-Alzheimer's disease agents","volume":"59","author":"Montanari","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.003_b0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmech.2012.12.046","article-title":"Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents","volume":"62","author":"Duan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2019.03.003_b0195","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1002\/anie.201302462","article-title":"Alkyne phosphonites for sequential azide-azide couplings","volume":"52","author":"Vallee","year":"2013","journal-title":"Angew. Chem.-Int. Ed."},{"issue":"4","key":"10.1016\/j.bioorg.2019.03.003_b0200","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/pola.24499","article-title":"Block-Brush Copolymers via ROMP and sequential double click reaction strategy","volume":"49","author":"Dag","year":"2011","journal-title":"J. Polym. Sci. Part a-Polym. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14756366.2016.1250753","article-title":"Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors","volume":"32","author":"Sonmez","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.003_b0210","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"#cr-split#-10.1016\/j.bioorg.2019.03.003_b0215.1","doi-asserted-by":"crossref","unstructured":"(a) A. Maresca, C. Temperini, H. Vu, N.B. Pham, S.A. Poulsen, A. Scozzafava, R.J. Quinn, C.T. Supuran, Non-Zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors, J. Am. Chem. Soc. 2009, 131, 3057-3062","DOI":"10.1021\/ja809683v"},{"key":"#cr-split#-10.1016\/j.bioorg.2019.03.003_b0215.2","doi-asserted-by":"crossref","unstructured":"(b) A. Maresca, C.T. Supuran, Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II, Bioorgan. Med. Chem. Lett. 2010, 20, 4511-4514.","DOI":"10.1016\/j.bmcl.2010.06.040"},{"key":"10.1016\/j.bioorg.2019.03.003_h0220","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0223-5234(96)85163-4","article-title":"Carbonic Anhydrase Inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes","volume":"31","author":"Supuran","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.003_h0225","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1021\/jm300031j","article-title":"Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo","volume":"55","author":"Carta","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.003_h0230","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","article-title":"7,8-disubstituted but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.03.003_h0235","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm901524f","article-title":"The coumarin- binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors","volume":"53","author":"Temperini","year":"2010","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.03.003_b0230","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/jm901524f","article-title":"The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors","volume":"53","author":"Temperini","year":"2009","journal-title":"J. Med. Chem."},{"issue":"33","key":"10.1016\/j.bioorg.2019.03.003_b0235","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1021\/acs.biochem.6b00243","article-title":"The structure of carbonic anhydrase IX is adapted for low-pH catalysis","volume":"55","author":"Mahon","year":"2016","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bioorg.2019.03.003_b0240","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cmdc.201600509","article-title":"Intrinsic thermodynamics and structures of 2, 4-and 3, 4-substituted fluorinated benzenesulfonamides binding to carbonic anhydrases","volume":"12","author":"Zubrien\u0117","year":"2017","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.bioorg.2019.03.003_b0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"3","key":"10.1016\/j.bioorg.2019.03.003_b0250","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/prot.22102","article-title":"Very fast prediction and rationalization of pKa values for protein\u2013ligand complexes","volume":"73","author":"Bas","year":"2008","journal-title":"Proteins Struct. Funct. Bioinf."},{"issue":"12","key":"10.1016\/j.bioorg.2019.03.003_b0255","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0260","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2019.03.003_b0265","unstructured":"Schr\u00f6dinger, LLC, New York, NY, 2017."},{"key":"10.1016\/j.bioorg.2019.03.003_b0270","unstructured":"Desmond Molecular Dynamics System, D. E. S. R., New York, NY, 2017. Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY, 2017."},{"key":"10.1016\/j.bioorg.2019.03.003_b0275","unstructured":"Schr\u00f6dinger, LigPrep, S., LLC, New York, NY, 2017."},{"issue":"3","key":"10.1016\/j.bioorg.2019.03.003_b0280","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"issue":"20","key":"10.1016\/j.bioorg.2019.03.003_b0285","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1021\/jm050543p","article-title":"Modeling water molecules in protein\u2212ligand docking using GOLD","volume":"48","author":"Verdonk","year":"2005","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.003_b0290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein\u2212ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J. Chem. Inf. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819301713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819301713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:55:59Z","timestamp":1758614159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819301713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":61,"alternative-id":["S0045206819301713"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.003","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}